Related Experiment Video
Updated: Jun 5, 2026
12:37
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Melanocortin-5 receptor and sebogenesis
Li Zhang1, Wen-Hwa Li, Michael Anthonavage
1The Johnson & Johnson Skin Research Center, Consumer Product Worldwide, a unit of Johnson & Johnson Consumer Companies, Inc.,199 Grandview Rd., Skillman, NJ 08558, USA. lzhang1@its.jnj.com
European Journal of Pharmacology
|January 11, 2011
Summary
Melanocortin MC(5) receptor antagonists can reduce sebum production. These compounds show promise for treating acne and other sebaceous disorders characterized by excess sebum.
Area of Science:
- Dermatology and endocrinology, focusing on skin lipid regulation.
Background:
- Melanocortins (α-MSH, β-MSH, γ-MSH, and ACTH) signal via melanocortin receptors, influencing biological processes.
- Human sebaceous glands express MC(5) and MC(1) receptors; excessive sebum production contributes to acne pathogenesis.
- MC(5) receptor expression correlates with sebocyte differentiation and sebum production, with α-MSH acting as a sebotropic hormone in rodents.
Purpose of the Study:
- To investigate melanocortin MC(5) receptor antagonists as potential agents for suppressing sebum production.
- To explore the therapeutic potential of MC(5) receptor antagonists for sebaceous disorders like acne.
Main Methods:
- Utilized MC(5) receptor antagonists to assess their effect on sebocyte differentiation in vitro.
- Evaluated the efficacy of MC(5) receptor antagonists in reducing sebum production in human skin xenografts on immunodeficient mice.
Main Results:
- MC(5) receptor antagonists inhibited sebocyte differentiation in vitro.
- Antagonists demonstrated a reduction in sebum production in human skin xenografts.
- Findings support the role of melanocortins in stimulating sebaceous lipid production via the MC(5) receptor.
Conclusions:
- Melanocortin MC(5) receptor antagonists are effective in reducing sebum production and sebocyte differentiation.
- MC(5) receptor antagonists represent a promising therapeutic strategy for managing acne and other conditions involving excessive sebum production.
Related Concept Videos
01:21Accessory Structures of the Skin: Sebaceous Glands
A sebaceous gland is a type of oil gland found almost all over the skin ( except palms and soles) and helps lubricate and waterproof the skin and hair. Most sebaceous glands are associated with hair follicles. They generate and excrete sebum, a mixture of lipids, onto the skin surface, thereby naturally lubricating the dry and dead layer of keratinized cells of the stratum corneum, keeping it pliable.
These glands that produce the oils on the skin and hair are holocrine glands. The mature...
These glands that produce the oils on the skin and hair are holocrine glands. The mature...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:25Cholinergic Receptors: Muscarinic
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...